These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 8370392)
1. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones. Demotz S Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392 [TBL] [Abstract][Full Text] [Related]
2. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta. Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476 [TBL] [Abstract][Full Text] [Related]
3. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line. Ramachandra L; Kovats S; Eastman S; Rudensky AY J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909 [TBL] [Abstract][Full Text] [Related]
4. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029 [TBL] [Abstract][Full Text] [Related]
5. T cell recognition of allopeptides in context of syngeneic MHC. Liu Z; Braunstein NS; Suciu-Foca N J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797 [TBL] [Abstract][Full Text] [Related]
6. Requirements for stimulation or anergy induction in alloreactive human T cell clones. Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128 [TBL] [Abstract][Full Text] [Related]
7. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line. Yamamoto M; Yano A J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233 [TBL] [Abstract][Full Text] [Related]
8. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules. Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789 [TBL] [Abstract][Full Text] [Related]
9. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide. Long EO; LaVaute T; Pinet V; Jaraquemada D J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228 [TBL] [Abstract][Full Text] [Related]
10. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines. Santamaria P; Boyce-Jacino MT; Lindstrom AL; Rich SS; Faras AJ; Barbosa JJ J Immunol; 1991 Mar; 146(6):1822-8. PubMed ID: 1706381 [TBL] [Abstract][Full Text] [Related]
11. T cells specific for different antigens express different HLA-D region products. Schendel DJ; Johnson JP Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791 [TBL] [Abstract][Full Text] [Related]
12. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain. Hitzel C; van Endert P; Koch N J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression. Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957 [TBL] [Abstract][Full Text] [Related]
14. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells. Sant AJ J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935 [TBL] [Abstract][Full Text] [Related]
15. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
16. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Demotz S; Barbey C; Corradin G; Amoroso A; Lanzavecchia A Eur J Immunol; 1993 Feb; 23(2):425-32. PubMed ID: 7679644 [TBL] [Abstract][Full Text] [Related]
17. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
18. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells. Wyss-Coray T; Brander C; Frutig K; Pichler WJ Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313 [TBL] [Abstract][Full Text] [Related]
19. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524 [TBL] [Abstract][Full Text] [Related]
20. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition. Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]